PROCOMP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Procomp, and what generic alternatives are available?
Procomp is a drug marketed by Jubilant Cadista and is included in one NDA.
The generic ingredient in PROCOMP is prochlorperazine maleate. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Procomp
A generic version of PROCOMP was approved as prochlorperazine maleate by NOVITIUM PHARMA on June 13th, 2022.
Summary for PROCOMP
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 12 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROCOMP at DailyMed |
Pharmacology for PROCOMP
Drug Class | Phenothiazine |
Anatomical Therapeutic Chemical (ATC) Classes for PROCOMP
US Patents and Regulatory Information for PROCOMP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jubilant Cadista | PROCOMP | prochlorperazine maleate | TABLET;ORAL | 040268-001 | Feb 27, 1998 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Jubilant Cadista | PROCOMP | prochlorperazine maleate | TABLET;ORAL | 040268-002 | Feb 27, 1998 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |